Cessatech AS - Unit (2 Ordinary sha

FRA:8GN (Denmark)   Unit (2 Ordinary shares & 3 Wrts)
€ 0.74 (-1.85%) May 22
At Loss
Market Cap:
€ 13.78M ($ 14.92M)
Enterprise V:
€ 11.76M ($ 12.74M)
Volume:
-
Avg Vol (2M):
46.00
Also Trade In:

Business Description

Description
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -0.23
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
5-Day RSI 36.66
9-Day RSI 43.51
14-Day RSI 47.03
6-1 Month Momentum % 39.85
12-1 Month Momentum % 213.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.8
Quick Ratio 0.8
Cash Ratio 0.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -55.3
Name Current Vs Industry Vs History
ROE % -205.3
ROA % -147.59
ROIC % -444.59
ROC (Joel Greenblatt) % -1133.72
ROCE % -174.22

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -3.9
EV-to-EBITDA -3.9
EV-to-FCF -5.17
Earnings Yield (Greenblatt) % -25.64
FCF Yield % -19.42

Financials (Next Earnings Date:2024-08-21)

FRA:8GN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cessatech AS Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.23
Beta -0.32
Volatility % 141.33
14-Day RSI 47.03
14-Day ATR (€) 0.029783
20-Day SMA (€) 0.77
12-1 Month Momentum % 213.22
52-Week Range (€) 0.202 - 0.948
Shares Outstanding (Mil) 17.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cessatech AS Filings

Filing Date Document Date Form
No Filing Data

Cessatech AS Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Cessatech AS Frequently Asked Questions

What is Cessatech AS(FRA:8GN)'s stock price today?
The current price of FRA:8GN is €0.74. The 52 week high of FRA:8GN is €0.95 and 52 week low is €0.20.
When is next earnings date of Cessatech AS(FRA:8GN)?
The next earnings date of Cessatech AS(FRA:8GN) is 2024-08-21.
Does Cessatech AS(FRA:8GN) pay dividends? If so, how much?
Cessatech AS(FRA:8GN) does not pay dividend.

Press Release

Subject Date
No Press Release